TOPISCHE ZUSAMMENSETZUNG

Patent europeic · EP2214642 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2214642
Numer da la dumonda
EP08844931
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
27-10-2008
Publitgà
11-08-2010
Concedì
03-05-2017
Stritgà
10-03-2021
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
A61K 9/00 (2006.01)
A61K 31/196 (2006.01)
A61K 9/06 (2006.01)
A61K 9/107 (2006.01)
Prioritad
EP 07119599 30.10.2007
Dumonda PCT
PCT/EP2008/064533 27.10.2008
Publicaziun PCT
WO2009/056522 07.05.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 10-03-2021

    Midada

    Published in Swissreg on 10.03.2021

  2. 07-06-2019

    Adressa midada

    Owner
    Novartis Consumer Health S.A., Route de l'Etraz 2, 1197 Prangins → GSK Consumer Healthcare S.A., Route de l'Etraz 2, 1197 Prangins

    Published in Swissreg on 07.06.2019

  3. 08-07-2017

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 08.07.2017

  4. 03-05-2017

    Concedì

    Published in Swissreg on 03.05.2017

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.